Back to trial detailsIntake questionnaire
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Applying to Providence Portland Medical Center · Portland, Oregon
Answer a few short questions to share with the research team.
0 of 4 answered